AT351176B - Verfahren zur herstellung von neuen salzen von pyridoxin-5'-phosphorsaeureestern mit amino- saeuren - Google Patents

Verfahren zur herstellung von neuen salzen von pyridoxin-5'-phosphorsaeureestern mit amino- saeuren

Info

Publication number
AT351176B
AT351176B AT827175A AT827175A AT351176B AT 351176 B AT351176 B AT 351176B AT 827175 A AT827175 A AT 827175A AT 827175 A AT827175 A AT 827175A AT 351176 B AT351176 B AT 351176B
Authority
AT
Austria
Prior art keywords
pyridoxin
production
amino acids
phosphoric acid
acid esters
Prior art date
Application number
AT827175A
Other languages
English (en)
Other versions
ATA827175A (de
Inventor
Rolf Dr Eurich
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of ATA827175A publication Critical patent/ATA827175A/de
Application granted granted Critical
Publication of AT351176B publication Critical patent/AT351176B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT827175A 1974-12-24 1975-10-30 Verfahren zur herstellung von neuen salzen von pyridoxin-5'-phosphorsaeureestern mit amino- saeuren AT351176B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1726174A CH607773A5 (en) 1974-12-24 1974-12-24 Process for the preparation of novel pyridoxine derivatives

Publications (2)

Publication Number Publication Date
ATA827175A ATA827175A (de) 1978-12-15
AT351176B true AT351176B (de) 1979-07-10

Family

ID=4423990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT827175A AT351176B (de) 1974-12-24 1975-10-30 Verfahren zur herstellung von neuen salzen von pyridoxin-5'-phosphorsaeureestern mit amino- saeuren

Country Status (5)

Country Link
AT (1) AT351176B (de)
CH (1) CH607773A5 (de)
GB (1) GB1478560A (de)
NL (1) NL183890C (de)
SE (1) SE422463B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288716A (en) * 1987-02-18 1994-02-22 Ulrich Speck Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and atherosclerosis
DE3705549A1 (de) * 1987-02-18 1988-09-01 Ulrich Speck Verwendung von pyridoxin-derivaten bei der prophylaxe und therapie von hyperlipidaemien und atherosklerose
US6716858B1 (en) 1995-08-28 2004-04-06 Kansas University Medical Center Methods for inhibiting diabetic complications
US6228858B1 (en) 1995-09-12 2001-05-08 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US6740668B1 (en) 1995-08-28 2004-05-25 Kansas University Medical Center Methods for inhibiting diabetic complications
US6730686B1 (en) 1995-09-12 2004-05-04 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins
US5744451A (en) 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
US6750209B1 (en) 1995-09-12 2004-06-15 Kansas University Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US7030146B2 (en) 1996-09-10 2006-04-18 University Of South Carolina Methods for treating diabetic neuropathy
CA2347117C (en) * 1998-10-22 2006-01-24 University Of South Carolina Methods for inhibiting diabetic complications

Also Published As

Publication number Publication date
SE422463B (sv) 1982-03-08
NL183890C (nl) 1989-02-16
CH607773A5 (en) 1978-10-31
NL183890B (nl) 1988-09-16
NL7514618A (nl) 1976-06-28
GB1478560A (en) 1977-07-06
SE7514203L (sv) 1976-06-25
ATA827175A (de) 1978-12-15

Similar Documents

Publication Publication Date Title
AT340892B (de) Verfahren zur herstellung von neuen 1-aminomethyl-1-cycloalkanessigsauren und deren estern sowie salzen
AT349000B (de) Verfahren zur herstellung von neuen trans-4- cyclohexan-1-carbonsaeureestern
AT348999B (de) Verfahren zur herstellung von neuen biphenylcarbonsaeureestern
AT343637B (de) Verfahren zur herstellung von neuen phenylessigsauren und deren alkylestern
AT351176B (de) Verfahren zur herstellung von neuen salzen von pyridoxin-5'-phosphorsaeureestern mit amino- saeuren
ATA175974A (de) Verfahren zur herstellung von aetherpolycarbonsaeuren und deren alkalisalzen
ATA175874A (de) Verfahren zur herstellung von aetherpolycarbonsaeuren und deren alkalisalzen
AT333306B (de) Verfahren zur herstellung von neuen pyrimidinylthionophosphonsaureestern
AT344161B (de) Verfahren zur herstellung von neuen phenoxyalkancarbonsaeureamiden von thiazolidincarbonsaeuren und ihren salzen
ATA953474A (de) Verfahren zur herstellung von neuen acylaminocephemcarbonsauren und von deren salzen und estern
ATA638275A (de) Verfahren zur herstellung von neuen cinnolin-3-yl-carbonsauren und von deren salzen
ATA329875A (de) Verfahren zur herstellung von salzen von poly-alfa-hydroxyacrylsauren
ATA371575A (de) Verfahren zur herstellung von neuen pharmazeutisch zulassigen saureadditionssalzen von 1,1,-dialkyl-n-butylaminen
AT332886B (de) Verfahren zur herstellung von neuen n-dithiophosphoryl-carbaminsaureestern
AT321944B (de) Verfahren zur herstellung von neuen o-triazolyl thionophosphor(phosphon)-säureestern bzw.- esteramiden
ATA940875A (de) Verfahren zur herstellung von 7-acylamido-3-methyl-3-cephem-4-carbonsaureestern
AT329079B (de) Verfahren zur herstellung von neuen o-athyl-o-n-propyl -o- vinyl-thionophosphorsaureestern
AT338753B (de) Verfahren zur herstellung von neuen 1,4-bis-formyl-cyclohexan-polycarbonsauren
AT341505B (de) Verfahren zur herstellung von neuen phenylalkansauren, deren estern oder amiden und deren salzen
AT330203B (de) Verfahren zur herstellung von neuen pyrimidin (2) yl-thionophosphorsaureestern
AT346310B (de) Verfahren zur herstellung von magnesiumsalzen von phenoxyalkansaeuren
ATA424575A (de) Verfahren zur herstellung von neuen aminoalkylphenoxyalkansaeuren, deren estern und salzen
ATA125178A (de) Verfahren zur herstellung von neuen amino- alkylphenoxyalkansaeuren und deren estern und salzen
AT339881B (de) Verfahren zur herstellung von 2- (4'-isobutylphenyl)-propiohydroxamsaure
ATA125278A (de) Verfahren zur herstellung von neuen amino- alkylphenoxyalkansaeuren, deren estern und salzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1680425

Country of ref document: EP

REN Ceased due to non-payment of the annual fee